Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2024
|
Ilya Yuffa EVP & President, LLY Int'l |
BUY
Exercise of conversion of derivative security
|
Direct |
3,702
+18.17%
|
-
|
|
Feb 01
2024
|
Anne E. White EVP & Pres, Lilly Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
1,844
-2.97%
|
$1,189,380
$645.61 P/Share
|
|
Feb 01
2024
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Exercise of conversion of derivative security
|
Direct |
4,124
+6.23%
|
-
|
|
Feb 01
2024
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,685
-10.9%
|
$1,086,825
$645.61 P/Share
|
|
Feb 01
2024
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,618
+18.96%
|
-
|
|
Jan 31
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
78,573
-0.0%
|
$51,386,742
$654.18 P/Share
|
|
Jan 30
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
76,215
-0.04%
|
$49,158,675
$645.69 P/Share
|
|
Jan 29
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
54,032
-0.05%
|
$34,850,640
$645.07 P/Share
|
|
Jan 16
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.58%
|
$9,510
$634.57 P/Share
|
|
Jan 16
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.15%
|
$14,582
$634.57 P/Share
|
|
Jan 16
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.76%
|
$10,144
$634.57 P/Share
|
|
Jan 16
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.04%
|
$12,046
$634.57 P/Share
|
|
Jan 16
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.1%
|
$10,144
$634.57 P/Share
|
|
Jan 16
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
1,180
-0.0%
|
$761,100
$645.85 P/Share
|
|
Jan 11
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
12,344
-0.0%
|
$7,826,096
$634.45 P/Share
|
|
Jan 10
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
163,730
-0.02%
|
$103,641,090
$633.44 P/Share
|
|
Jan 09
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
34,538
-0.01%
|
$21,828,016
$632.01 P/Share
|
|
Jan 04
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
14,388
-0.01%
|
$9,064,440
$630.65 P/Share
|
|
Dec 18
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.16%
|
$14,475
$579.76 P/Share
|
|
Dec 18
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.43%
|
$5,211
$579.76 P/Share
|
|
Dec 18
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.02%
|
$9,843
$579.76 P/Share
|
|
Dec 18
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.18%
|
$9,843
$579.76 P/Share
|
|
Dec 18
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.66%
|
$9,843
$579.76 P/Share
|
|
Dec 18
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.04%
|
$11,580
$579.76 P/Share
|
|
Dec 01
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,142
-22.5%
|
$1,265,922
$591.04 P/Share
|
|
Dec 01
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,810
+33.57%
|
-
|
|
Nov 20
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
354
+0.33%
|
$211,338
$597.6 P/Share
|
|
Nov 20
2023
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+1.57%
|
$199,995
$597.6 P/Share
|
|
Nov 20
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
343
+7.23%
|
$204,771
$597.6 P/Share
|
|
Nov 20
2023
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+5.37%
|
$199,995
$597.6 P/Share
|
|
Nov 20
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
351
+6.17%
|
$209,547
$597.6 P/Share
|
|
Nov 20
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
359
+1.14%
|
$214,323
$597.6 P/Share
|
|
Nov 20
2023
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+1.98%
|
$199,995
$597.6 P/Share
|
|
Nov 20
2023
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+1.46%
|
$199,995
$597.6 P/Share
|
|
Nov 20
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
352
+0.24%
|
$210,144
$597.6 P/Share
|
|
Nov 20
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
352
+10.42%
|
$210,144
$597.6 P/Share
|
|
Nov 20
2023
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
335
+3.67%
|
$199,995
$597.6 P/Share
|
|
Nov 14
2023
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
15,000
-3.41%
|
-
|
|
Nov 10
2023
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Bona fide gift
|
Direct |
17
-0.02%
|
-
|
|
Nov 06
2023
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
670
-12.46%
|
$382,570
$571.1 P/Share
|
|
Oct 16
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.46%
|
$4,928
$616.64 P/Share
|
|
Oct 16
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+1.5%
|
$9,856
$616.64 P/Share
|
|
Oct 16
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.72%
|
$9,856
$616.64 P/Share
|
|
Oct 16
2023
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.15%
|
$14,168
$616.64 P/Share
|
|
Oct 16
2023
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.03%
|
$11,088
$616.64 P/Share
|
|
Oct 16
2023
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.02%
|
$9,856
$616.64 P/Share
|
|
Oct 11
2023
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
215,000
-0.04%
|
$130,075,000
$605.51 P/Share
|
|
Sep 18
2023
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.52%
|
$5,139
$571.28 P/Share
|
|
Sep 18
2023
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+1.62%
|
$9,707
$571.28 P/Share
|
|
Sep 18
2023
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.77%
|
$9,707
$571.28 P/Share
|